What is the recommendation for the use of prasugrel in patients with NSTE-ACS?
The use of prasugrel is not recommended for upfront therapy in patients with NSTE-ACS. The recommendation is to administer prasugrel only at the time of PCI, as per the results of the TRITON, TRILOGY ACS, and ACCOAST trials.